octane has been researched along with glucagon-like peptide 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aspnes, GE; Bagley, SW; Coffey, SB; Conn, EL; Curto, JM; Edmonds, DJ; Genovino, J; Griffith, DA; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Rose, CR; Ruggeri, RB; Wei, L | 1 |
1 other study(ies) available for octane and glucagon-like peptide 1
| Article | Year |
|---|---|
6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor.
Topics: Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; High-Throughput Screening Assays; Humans; Hypoglycemic Agents; Octanes; Spiro Compounds | 2023 |